Company intelligence / Profile preview

PLUS Diagnostics

Union, New Jersey, United Statesbiospace.com ↗

Ownership: Private
Employees: ~400
Development stage: Commercial

Overview

PLUS Diagnostics was a leading national anatomic pathology laboratory providing multi-specialty diagnostic services—including advanced hematopathology and oncology testing—before being acquired by Miraca Life Sciences in October 2013. The company was recognized for its innovation in flow cytometry and error-prevention technologies.

Therapeutic areas: OncologyDermatologyGastroenterologyMen's Health
Modalities: Diagnostic testing (anatomic pathology, cytology, histology, molecular pathology)Flow cytometry
Industry: Pathology

Partnerships

Water Street Healthcare Partners

Beyond the preview

Go deeper on PLUS Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PLUS Diagnostics.

Explore the full profile